Practice-Changing Research Shows Imfinzi, a Type of Immunotherapy, Significantly Increases Survival for Certain Small Cell Lung Cancers

The research provides hope for small cell lung cancer, a more rare and often fast growing form of the disease. Imfinzi could reduce the risk of death by 27%.